Viewing Study NCT01558661


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2026-01-03 @ 3:27 AM
Study NCT ID: NCT01558661
Status: COMPLETED
Last Update Posted: 2017-11-28
First Post: 2012-03-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 12-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View
None INDUSTRY View